Operator
Hiya, and thanks for standing by. Presently, I want to welcome everybody to the CareDx Investor Webinar Name. [Operator Instructions]
I might now like to show the convention over to Natasha Wagner. It’s possible you’ll start.
Natasha Moshirian Wagner
Hiya, and thanks for becoming a member of us. I am Natasha Wagner, VP of Company Communications at CareDx. Welcome to our investor webcast centered on AlloHeme, advancing AI-enabled relapse monitoring in AML and MDS post-cell remedy, positioning CareDx to steer in precision medication for cell remedy.
I would like to start out at present’s name by reminding everybody of our protected harbor assertion. These slides and the accompanying oral presentation comprise forward-looking statements. All statements aside from statements of historic reality contained on this presentation, together with statements concerning the long run enterprise plans and goals, potential development alternatives, aggressive place, trade atmosphere and potential market alternatives of CareDx, along with its subsidiaries, CareDx or the corporate, CareDx’s capability to generate income and enhance the industrial success of its present and future testing providers, merchandise and sufferers and digital options and the result or success of CareDx’s scientific trial collaborations and registry research are forward-looking statements.
The phrases imagine, might, will, doubtlessly, estimate, proceed, anticipate, intend, may, ought to, would, mission, plan, goal, ponder, predict, count on and the damaging and plural types of these phrases and comparable expressions are supposed to determine that CareDx has primarily based these
